Tag: FDA-approved prostate drugs 2024

Home / FDA-approved prostate drugs 2024

Categories

Enzalutamide is approved by the USFDA for non-metastatic castration-sensitive prostate cancer with biochemical recurrence

The FDA has authorized enzalutamide for the treatment of non-metastatic castration-sensitive prostate cancer in cases of biochemical recurrence.The Food and Drug Administration approved enzalutamide ...
fda-approved-prostate-drugs-2024

Scan the code